Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Centessa Pharmaceuticals plc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| HUSSAIN IQBAL J (General Counsel) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 7,520 shares
@ $6.47, valued at
$48.7k
|
|
| 10/03/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,700 shares
@ $6.47, valued at
$30.4k
|
|
| 10/03/2023 |
4
| Weinhoff Gregory M (CFO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 11,742 shares
@ $6.47, valued at
$76k
|
|
| 10/03/2023 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 36,263 shares
@ $6.47, valued at
$234.6k
|
|
| 10/03/2023 |
4
| CHAO DAVID M (Chief Administrative Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 10,419 shares
@ $6.47, valued at
$67.4k
|
|
| 10/03/2023 |
4
| Bush Tia L (Chief Quality Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 6,419 shares
@ $6.47, valued at
$41.5k
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Weinhoff Gregory M (CFO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 11,742 shares
@ $5.9001, valued at
$69.3k
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2023 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Sold 6,500 shares
@ $4.4537, valued at
$28.9k
|
|
| 05/26/2023 |
4
| Bush Tia L (Chief Quality Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Sold 5,000 shares
@ $4.485, valued at
$22.4k
Sold 3,000 shares
@ $4.4801, valued at
$13.4k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| CHAO DAVID M (Chief Administrative Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 6,969 shares
@ $3.9, valued at
$27.2k
|
|
| 04/04/2023 |
4
| Weinhoff Gregory M (CFO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 8,292 shares
@ $3.9, valued at
$32.3k
|
|
| 04/04/2023 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,103 shares
@ $3.9, valued at
$16k
|
|
| 04/04/2023 |
4
| SAHA SAURABH (CEO) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 22,013 shares
@ $3.9, valued at
$85.9k
|
|
| 04/04/2023 |
4
| HUSSAIN IQBAL J (General Counsel) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 7,080 shares
@ $3.9, valued at
$27.6k
|
|
| 04/04/2023 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 3,615 shares
@ $3.9, valued at
$14.1k
Sold 6,700 shares
@ $3.691, valued at
$24.7k
|
|
| 04/04/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,825 shares
@ $3.9, valued at
$18.8k
|
|
| 04/04/2023 |
4
| Bush Tia L (Chief Quality Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,319 shares
@ $3.9, valued at
$16.8k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Templeman Thomas (Chief Technology Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 5,382 shares
@ $4.25, valued at
$22.9k
|
|
| 01/13/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 7,154 shares
@ $4.25, valued at
$30.4k
|
|
|
|
|